Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Hsih-Te Yang"'
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 5287-5295 (2022)
Synthetic lethality (SL) is an emerging therapeutic paradigm in cancer. We introduced a different approach to prioritize SL gene pairs through literature mining and RAS-mutant high-throughput screening (HTS) data. We matched essential genes from text
Externí odkaz:
https://doaj.org/article/58c2c05b14ea4763bed3470ab01bba04
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/96503df8fe0b41fa89285589c2a9a2fe
Autor:
Hsih-Te Yang, Minoru S H Ko
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e32376 (2012)
It is widely accepted that gene expression regulation is a stochastic event. The common approach for its computer simulation requires detailed information on the interactions of individual molecules, which is often not available for the analyses of b
Externí odkaz:
https://doaj.org/article/07a562c6f60f412a845a7ea9a0dbdfed
Autor:
Hsih-Te Yang, 楊士德
96
Systems biology aims to study biology from a system’s point of view. Such studies usually involve creating a computational model to integrate relevant experimental data in such a way that the resulting model could be used to discover novel
Systems biology aims to study biology from a system’s point of view. Such studies usually involve creating a computational model to integrate relevant experimental data in such a way that the resulting model could be used to discover novel
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/19045275772410641041
Autor:
Srinivasa Reddy Sanikommu, Shebli Atrash, Myra Robinson, Nury M. Steuerwald, Kristen Cassetta, Hsih-Te Yang, Saad Usmani, Edward A. Copelan, Belinda R. Avalos, Lawrence J. Druhan
Publikováno v:
Blood. 140:11416-11417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7af3c845b771b5310caecc1955b9eb71
https://doi.org/10.1182/blood-2022-170887
https://doi.org/10.1182/blood-2022-170887
Publikováno v:
Cancer Management and Research. 11:7525-7536
The decreasing cost of and increasing capacity of DNA sequencing has led to vastly increased opportunities for population-level genomic studies to discover novel genomic alterations associated with both Mendelian and complex phenotypes. To translate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6014796317f8bba46f063f5e202a33c
https://doi.org/10.2147/cmar.s201326
https://doi.org/10.2147/cmar.s201326
Autor:
Ellen Shannon Story, Hsih-Te Yang, Ashley Stewart, Carol J. Farhangfar, Brittany Neelands, Nury Steuerwald, Erin E Donahue, James Thomas Symanowski, Zvonimir Milas, Daniel Brickman, Catherine Frenkel, Shwetha Sudhakar
Publikováno v:
Journal of Clinical Oncology. 40:e18083-e18083
e18083 Background: The value of sequencing cell-free DNA (cfDNA) from patients with papillary carcinoma of the thyroid (PTC) is controversial. Studies utilizing whole-exome sequencing (WES) or single-gene detection methods have reported lower mutatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a111d1bc05ca977d563e284beaf71670
https://doi.org/10.1200/jco.2022.40.16_suppl.e18083
https://doi.org/10.1200/jco.2022.40.16_suppl.e18083
Autor:
Mohamed E. Salem, Hsih-Te Yang, Wei Sha, James Thomas Symanowski, Alberto Puccini, Jimmy J. Hwang, Kunal C. Kadakia, Laura W. Musselwhite, Edward S. Kim, Thomas J. George, David Foureau
Publikováno v:
Journal of Clinical Oncology. 40:157-157
157 Background: Pembrolizumab did not improve neoadjuvant rectal score when added to neoadjuvant CRT in the NRG-GI002 study. The impact of CRT on TME in patients (pts) with rectal cancer (RC) has not been well characterized. Methods: We performed a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7aef126a0d4ee38e465c5ed6391dcc2
https://doi.org/10.1200/jco.2022.40.4_suppl.157
https://doi.org/10.1200/jco.2022.40.4_suppl.157
Autor:
Hsih-Te Yang1,2, Jiun-Huang Ju3, Yue-Ting Wong4, Shmulevich, Ilya5, Jung-Hsien Chiang6 jchiang@mail.ncku.edu.tw
Publikováno v:
Briefings in Bioinformatics. May2017, Vol. 18 Issue 3, p488-497. 10p.
Autor:
David M. Foureau, Edward A. Copelan, Lawrence J. Druhan, Scott C Jaros, Sarah E Teague, Rajeswaran Mani, Donald L. Durden, Samon Benrashid, Nilanjan Ghosh, Hsih-Te Yang, Steven I. Park, Belinda R. Avalos, Nury Steuerwald
Publikováno v:
Blood. 138:682-682
Venetoclax (VEN), a BCL2 specific inhibitor, has shown excellent clinical activities in various types of non-Hodgkin lymphoma, and it is FDA-approved in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). However, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3db0543e373c21594adb9653f1660238
https://doi.org/10.1182/blood-2021-146064
https://doi.org/10.1182/blood-2021-146064